School of Medicine
Showing 1,291-1,300 of 1,352 Results
-
Arthur Sung, MD, FCCP
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Sung is a highly esteemed, fellowship-trained interventional pulmonologist and a fellow of the American College of Chest Physicians.
He is the senior associate chief of the Stanford Medicine Division of Pulmonary, Allergy and Critical Care Medicine. He founded the interventional pulmonology and bronchoscopy for Stanford Medicine in 2013. With Stanford University School of Medicine, he is a clinical associate professor of medicine – pulmonary, allergy and critical care medicine.
In his clinical practice, Dr. Sung delivers care at Stanford Medicine sites in both Palo Alto, Emeryville and Livermore. He is a recognized expert in the diagnosis and treatment of conditions involving the chest and lungs, including complex airway diseases.
Patients praise the quality of his care and excellent listening skills. They highlight his ability to answer questions and to explain medical conditions and treatment options clearly and compassionately.
To advance the field of pulmonology, Dr. Sung is conducting research in airways diseases. He is a principal investigator of a study of variables in computed tomography imaging used to support diagnostic and treatment approaches. He previously served as the site principal investigator for lung volume reduction procedure for COPD.
Dr. Sung has co-authored articles published in the Journal of Thoracic Oncology, Clinical Lung Cancer, Journal of Thoracic Imaging, Chest, and elsewhere. Topics have included innovations in therapy for pneumonitis and robotic surgical treatment of lung tumors.
He has written chapters for books such as Principles and Practice of Interventional Pulmonology, Examination of the Larynx through the Bronchoscope, and Airway Anatomy for the Bronchoscopist.
Dr. Sung has made presentations to the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. Topics have included lung cancer staging in the era of personalized medicine.
Dr. Sung has earned recognition from the College of Chest Physicians. The Stanford Leadership Program has recognized his achievements. From the Stanford University Bio-X program, he received a grant to study ultrasound-guided lung biopsy procedures. The Bio-X program fosters interdisciplinary collaboration among biomedical and life science researchers, clinicians, engineers, physicists, and computational scientists.
He is a member of the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. He has volunteered his time and expertise to deliver health care services to those in need. New Orleans Mayor Ray Nagins honored Dr. Sung for providing care to victims of Hurricane Katrina. -
C. Kwang Sung, MD, MS
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Music
Current Research and Scholarly InterestsLaryngology
Otolaryngology
Professional voice -
Ruey J. Sung
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsClinical and basic cardiac electrophysiology
-
Philip Sunshine
Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy primary interests are in the area of neonatal nutrition and developmental gastroenterology. The use of parenteral nutrition in very low birth weight infants, and the introduction of early enteral feeding to stimulate gastrointestinal maturation are my specific areas of investigative endeavors.
-
John B. Sunwoo, MD
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy laboratory is focused on two primary areas of research: (1) the immune response to head and neck cancer and to a tumorigenic population of cells within these malignancies called cancer stem cells; (2) the developmental programs of a special lymphocyte population involved in innate immunity called natural killer (NK) cells; and (3) intra-tumor and inter-tumor heterogeneity.
